Class 3 Device Recall Strep B Carrot Broth" OneStep

• Date Initiated by Firm: October 06, 2020
• Create Date: November 10, 2020
• Recall Status: Terminated on May 28, 2021
• Recall Number: Z-0441-2021
• Recall Event ID: 86586
• 510(K)Number: K170586
• Product Classification: GBS culture media, selective and differential - Product Code PQZ
• Product: Strep B Carrot Broth One-Step, Ref. Z40, UDI: 00819398026499
• Code Information: Lot # 465086
• Recalling Firm/ Manufacturer: Hardy Diagnostics; 1430 W McCoy Ln; Santa Maria CA 93455-1005
• For Additional Information Contact: Hardy Diagnostic Technical Services; 800-266-2222 Ext. 2
• Manufacturer Reason for Recall: Streptococcus culture medium contains an incorrect expiration date. The culture medium outer box labeling contains an expiration date of 2021-11-10 instead of the correct expiration date of 2020-11-10
• FDA Determined Cause: Employee error
• Action: Hardy Diagnostic sent a "Urgent: Recall Notification" on 9/30/2020 and sent a follow-up letter 10/06/2020 containing additional information. In addition to notifying consignees about the recall, the firm asked consignees to take the following actions: 1. Please respond to the notification within 10 business days of receipt of the letter, either through mail or email. 2. To respond by email, please scan and send the completed inventory reconciliation form (FORM-2023C) to TechService@HardyDiagnostics.com. After a response is received, new labels with the correct expiration date will be sent to you for product that has not yet been used. 3. Upon expiration of the product, on November 10, 2020, discard any remaining stock. This product should be destroyed according to local regulation as non-hazardous waste if un-inoculated or as medical waste if inoculated. 4. Please retain this letter or post the letter where the product is stored to ensure the users are aware of this defect. Additionally, please take the following actions: - Notify any and all employees who may use the product. - If the product was further distributed, notify the consignees the product was distributed to. 5. Any Adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online (www.fda.gov/medwatch/report.htm), by regular mail or by fax. 6. Please feel free to contact Technical Services if you have additional questions about this notification through email (listed above) or through phone call at (800) 266-2222, option 2, Monday through Friday, 8:00 AM to 5:00 PM, Pacific Time.
• Quantity in Commerce: 8,620 units
• Distribution: US: VA, AR, WI, ID, NY, AL, CA, MT, TX, MN, NH, WA, NC, NY, AZ, AK, MO, FL, MI, WY, ID, CO, AL, MT, WY, Puerto Rico, and Guam
• Total Product Life Cycle: TPLC Device Report

¹ A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
² Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
³ For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.

• 510(K) Database: 510(K)s with Product Code = PQZ